These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22806274)

  • 1. Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions.
    Wofsy D; Hillson JL; Diamond B
    Arthritis Rheum; 2012 Nov; 64(11):3660-5. PubMed ID: 22806274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of alternative primary outcome measures for use in lupus nephritis clinical trials.
    Wofsy D; Hillson JL; Diamond B
    Arthritis Rheum; 2013 Jun; 65(6):1586-91. PubMed ID: 23529285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy.
    Timlin H; Magder L; Petri M
    Cureus; 2017 Dec; 9(12):e1907. PubMed ID: 29410944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
    Furie R; Nicholls K; Cheng TT; Houssiau F; Burgos-Vargas R; Chen SL; Hillson JL; Meadows-Shropshire S; Kinaszczuk M; Merrill JT
    Arthritis Rheumatol; 2014 Feb; 66(2):379-89. PubMed ID: 24504810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.
    ACCESS Trial Group
    Arthritis Rheumatol; 2014 Nov; 66(11):3096-104. PubMed ID: 25403681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).
    Sinclair A; Appel G; Dooley MA; Ginzler E; Isenberg D; Jayne D; Wofsy D; Solomons N
    Lupus; 2007; 16(12):972-80. PubMed ID: 18042591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus nephritis.
    Sauter M; Anders HJ
    Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?
    Li EK; Tam LS; Zhu TY; Li M; Kwok CL; Li TK; Leung YY; Wong KC; Szeto CC
    Rheumatology (Oxford); 2009 Aug; 48(8):892-8. PubMed ID: 19478041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options for resistant lupus nephritis.
    Mok CC
    Semin Arthritis Rheum; 2006 Oct; 36(2):71-81. PubMed ID: 16884971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
    Morović-Vergles J; Galesić K; Dancuo I; Vergles D
    Acta Med Croatica; 2004; 58(1):13-7. PubMed ID: 15125388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids.
    Pepper R; Griffith M; Kirwan C; Levy J; Taube D; Pusey C; Lightstone L; Cairns T
    Nephrol Dial Transplant; 2009 Dec; 24(12):3717-23. PubMed ID: 19617257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].
    Frutos MA; Martín Gómez A; de Ramón E; Camps MT; Valera A; García I; Fernández Nebro A
    Nefrologia; 2007; 27(1):12-22. PubMed ID: 17402875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
    Fraenkel L; MacKenzie T; Joseph L; Kashgarian M; Hayslett JP; Esdaile JM
    J Rheumatol; 1994 Nov; 21(11):2052-7. PubMed ID: 7869309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.
    Mak SK; Lo KY; Lo MW; Chan SF; Tong GM; Wong PN; Wong AK
    Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial.
    Kremer JM; Dougados M; Emery P; Durez P; Sibilia J; Shergy W; Steinfeld S; Tindall E; Becker JC; Li T; Nuamah IF; Aranda R; Moreland LW
    Arthritis Rheum; 2005 Aug; 52(8):2263-71. PubMed ID: 16052582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.